- Home
- BBIO vs BEP Comparison
BBIO vs BEP Comparison
Compare BBIO & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BEP
- Stock Information
- Founded
- BBIO 2015
- BEP 1999
- Country
- BBIO United States
- BEP Canada
- Employees
- BBIO N/A
- BEP N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BEP Electric Utilities: Central
- Sector
- BBIO Health Care
- BEP Utilities
- Exchange
- BBIO Nasdaq
- BEP Nasdaq
- Market Cap
- BBIO 6.7B
- BEP 6.4B
- IPO Year
- BBIO 2019
- BEP N/A
- Fundamental
- Price
- BBIO $34.17
- BEP $23.27
- Analyst Decision
- BBIO Strong Buy
- BEP Buy
- Analyst Count
- BBIO 12
- BEP 7
- Target Price
- BBIO $57.09
- BEP $29.00
- AVG Volume (30 Days)
- BBIO 3.1M
- BEP 436.2K
- Earning Date
- BBIO 04-29-2025
- BEP 05-02-2025
- Dividend Yield
- BBIO N/A
- BEP 6.27%
- EPS Growth
- BBIO N/A
- BEP N/A
- EPS
- BBIO N/A
- BEP N/A
- Revenue
- BBIO $127,415,000.00
- BEP $5,964,000,000.00
- Revenue This Year
- BBIO $13.67
- BEP $14.36
- Revenue Next Year
- BBIO $118.02
- BEP $6.18
- P/E Ratio
- BBIO N/A
- BEP N/A
- Revenue Growth
- BBIO N/A
- BEP 14.71
- 52 Week Low
- BBIO $21.62
- BEP $19.29
- 52 Week High
- BBIO $39.47
- BEP $29.56
- Technical
- Relative Strength Index (RSI)
- BBIO 44.19
- BEP 60.36
- Support Level
- BBIO $33.92
- BEP $22.17
- Resistance Level
- BBIO $39.16
- BEP $23.59
- Average True Range (ATR)
- BBIO 1.50
- BEP 0.57
- MACD
- BBIO -0.24
- BEP 0.07
- Stochastic Oscillator
- BBIO 10.35
- BEP 83.92
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.